Dr. Eliana Nakano (Instituto Butantan São Paulo)
By searching for new compounds to schistosomiasis control, we aim to increase the current chemical arsenal available for this disease.
Dr. Bonnie Webster (Natural History Museum London): Molecular diagnostics for schistosomiasis
At ISNTD d³ 2017, Dr. Bonnie Webster from the Natural History Museum London speaks about recent research at the NHM to develop molecular dia
Dr. Valerie Oriol Mathieu (Janssen Vaccines & Prevention): Ebola & Filoviruses Vaccine Devel
At ISNTD d³ 2017, Dr. Valerie Oriol Mathieu, Global Medical Affairs Lead at Janssen Vaccines & Prevention, speaks about current challeng
Infectious Thoughts Interview: Enwono Eyoh (University of Edinburgh)
Enwono Eyoh speaks to the ISNTD about current research at the University of Edinburgh's Parasite Immuno-epidemiology group on a vaccine
Infectious Thoughts Interview: Dr. Benny Baeten (Johnson & Johnson)
Dr. Benny Baeten, Compound Development Team Leader for Anthelmintics at the Janssen Pharmaceutical Companies of Johnson & Johnson speaks
Panel discussion: Current gaps & research priorities for NTD drug discovery May 2017
Panel discussion at ISNTD d³ 2017, chaired by Mr. Duc H. Le, Editor in Chief at EBio Medicine. Panelists are: • Dr. Benny Baeten (J&J...
Dr. Stephan Goetz (Iceni Diagnostics): Carbohydrate diagnostics for infectious diseases
At the ISNTD d³ 2017 conference, Dr. Stephan Goetz, senior scientists at Iceni Diagnostics, speaks about the potential of carbohydrate diagn
Dr. Rita Oliveira (Imperial College London): Comparing standard and molecular diagnostics for STH
At ISNTD d³ 2017, Dr. Rita Oliveira, from Imperial College London, speaks about recent community-wide cross sectional study of Soil-Transmit
Dr. Victor del Rio Vilas (University of Surrey): The road to rabies elimination
At ISNTD d³ 2017, Dr. Victor del Rio Vilas (University of Surrey) speaks about "Inter-laboratory proficiency exercises and data integra
Pr. Simon Croft (LSHTM) Designing new treatments for leishmaniasis
Pr. Simon Croft (LSHTM) Designing new treatments for leishmaniasis
